We gratefully acknowledge support for our work by the following funding agencies:
Munich Cluster for Systems Neurology (SyNergy I+ II) (DFG)
Nov 2012 – Dec 2025
Aufdeckung der Rolle von seltenen und low-frequency Mutationen bei Schlaganfall mittels eines „polygenic risk score“ – informierten Sequenzieransatzes – Implikationen für die Risikoprädiktion / Martin Dichgans, Rainer Malik
Mai 2022 – April 2025
Forschergruppe „ImmunoStroke: Von der Immunzelle zur Schlagabfallregeneration“ (DFG) Teilprojekt C2 „Mikroglia-PET als Surogatmarker für Neuroinflammation nach Schlaganfall“ Martin Dichgans
Jul 2019 – Dec 2025
Forschergruppe „ImmunoStroke: Von der Immunzelle zur Schlagabfallregeneration“ (DFG) Arthur Liesz Teilprojekt A2: "Inflammasomes in post-stroke regeneration" Teilprojekt A3: "The role of microglia in cortical connectivity during recovery after stroke" Teilprojekt Z2: "Standardization of animal models and outcome parameters"
Jul 2019 – Dec 2025
CRC1123/project A2: Jürgen Bernhagen (together with Philipp von Hundelshausen, IPEK, LMU)–Interactions of chemokines with heterologous effectors in atherosclerosis (– Project within the collaborative research programme SFB 1123 ‘Atherosclerosis)
Jul 2022 – Jun 2026
CRC1123/project A3: Jürgen Bernhagen (together with Aphrodite Kapurniotu, TUM)–Differential mechanisms of MIF proteins in atherosclerosis and selective peptide-based intervention strategies (– Project within the collaborative research programme SFB 1123 ‘Atherosclerosis)
Jul 2022 – Jun 2026
CRC1123/project B3: Martin Dichgans/Yaw Asare – Mechanisms underlying the role of HDAC9 in atherosclerosis (Project within the collaborative research programme SFB 1123 ‘Atherosclerosis)
Jul 2022 – Jun 2026
CRC1123/project B11: Arthur Liesz (together with Hendrik Sager, TUM) – Inflammation begets inflammation – impact of remote injuries on atherosclerosis progression (Project within the collaborative research programme SFB 1123 ‘Atherosclerosis)
Jul 2022 – Jun 2026
Role of SCARF1 in Arterial Inflammation, Martin Dichgans / Yaw Asare
Mar 2023 – Feb 2026
Hertie-Stiftung: Early Clinical Proof of Concept-Studie
Apr 2024 – Apr 2029
CLINSPECT-M, CLINICAL MASS SPECTROMETRY CENTER MUNICH; Teilprojekt B: Neurovascular Diseases / Martin Dichgans
Mar 2020 – Feb 2026
Reprogrammed microglial cells as a therapeutic approach against Alzheimer's disease / Dominik Paquet
Apr 2025 – Dec 2027
DigiMed – P4 Medizin von Carotis Stenose und Schlaganfall (Bayerisches Staatsministerium für Gesundheit und Pflege)
Oct 2018 – Nov 2024
Vascular Dementia Research Foundation: The Institute for Stroke and Dementia Research
Fondation Leducq: Leducq Trans-Atlantic Network of Excellence On Circadian Effects in Stroke (CIRCA), Steffen Tiedt
Jan 2022 – Dec 2026
EU ERA-NET Neuron: Multidimensional interrogation of microvascular matrisome abnormalities in cerebral small vessel diseases (MatriSVDs), Martin Dichgans
Mar 2023 – Feb 2026
EU ERA-NET Neuron: Modulation of brain barrier function by microbiota-derived factors in cerebral ischemia, Corinne Benakis
Mar 2023 – Feb 2026
EU ERA-NET Neuron: The meninges as a new player in post-stroke recovery, Arthur Liesz
Mar 2023 – Feb 2026
EU ERA-NET Neuron: Role of oxidative stress for neuro-vascular function, Nikolaus Plesnila
Mar 2023 – Feb 2026
Horizon-EIC-2022-PathfinderChallenges
MultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disease (MIRACLE)
